Naseer Sangwan

Naseer Sangwan

Auto-generated profile, based on publicly available information

Naseer Sangwan

Department of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Ohio

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2018 in mSystems
Verified
Journal Article
Open access
PDF file
DMDaniel McDonald
Daniel McDonald
EHEmbriette Hyde
Embriette Hyde
JDJustine W. Debelius
Justine W. Debelius
JMJames T. Morton
James T. Morton
AGAntonio Gonzalez
Antonio Gonzalez
RKRob Knight
Rob Knight
We show that a citizen science, self-selected cohort shipping samples through the mail at room temperature recaptures many known microbiome results from clinically collected cohorts and reveals new ones. Of particular interest is integratingn= 1 study data with the population data, showing that the extent of microbiome change after events such as surgery can exceed differences between distinct environmental biomes, and the effect of diverse plants in the diet, which we confirm with untargeted metabolomics on hundreds of samples.

22 September 2015 in The ISME Journal
Verified
Journal Article
Open access
PDF file
RCRoberto Berni Canani
Roberto Berni Canani
NSNaseer Sangwan
Naseer Sangwan
ASAndrew T Stefka
Andrew T Stefka
RNRita Nocerino
Rita Nocerino
LPLorella Paparo
Lorella Paparo
CNCathryn R Nagler
Cathryn R Nagler
Dietary intervention with extensively hydrolyzed casein formula supplemented with Lactobacillus rhamnosus GG (EHCF+LGG) accelerates tolerance acquisition in infants with cow’s milk allergy (CMA). We examined whether this effect is attributable, at least in part, to an influence on the gut microbiota. Fecal samples from healthy controls (n=20) and from CMA infants (n=19) before and after treatment with EHCF with (n=12) and without (n=7) supplementation with LGG were compared by 16S rRNA-based operational taxonomic unit clustering and oligotyping. Differential feature selection and generalized linear model fitting revealed that the CMA infants have a diverse gut microbial community structure dominated by Lachnospiraceae (20.5±9.7%) and Ruminococcaceae (16.2±9.1%). Blautia, Roseburia and Coprococcus were significantly enriched following treatment with EHCF and LGG, but only one genus, Oscillospira, was significantly different between infants that became tolerant and those that remained allergic. However, most tolerant infants showed a significant increase in fecal butyrate levels, and those taxa that were significantly enriched in these samples, Blautia and Roseburia, exhibited specific strain-level demarcations between tolerant and allergic infants. Our data suggest that EHCF+LGG promotes tolerance in infants with CMA, in part, by influencing the strain-level bacterial community structure of the infant gut.

8 January 2016 in Science
Verified
Journal Article
Closed access
PDF file
JMJessica L. Metcalf
Jessica L. Metcalf
ZXZhenjiang Zech Xu
Zhenjiang Zech Xu
SWSophie Weiss
Sophie Weiss
SLSimon Lax
Simon Lax
WTWill Van Treuren
Will Van Treuren
RKRob Knight
Rob Knight
Decomposition spawns a microbial zoo: The death of a large animal represents a food bonanza for microorganisms. Metcalfet al.monitored microbial activity during the decomposition of mouse and human cadavers. Regardless of soil type, season, or species, the microbial succession during decomposition was a predictable measure of time since death. An overlying corpse leaches nutrients that allow soil- and insect-associated fungi and bacteria to grow. These microorganisms are metabolic specialists that convert proteins and lipids into foul-smelling compounds such as cadaverine, putrescine, and ammonia, whose signature may persist in the soil long after a corpse has been removed.Science, this issue p.158

24 May 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SLSimon Lax
Simon Lax
NSNaseer Sangwan
Naseer Sangwan
DSDaniel Smith
Daniel Smith
PLPeter Larsen
Peter Larsen
KHKim M. Handley
Kim M. Handley
JGJack A. Gilbert
Jack A. Gilbert
The microorganisms that inhabit hospitals may influence patient recovery and outcome, although the complexity and diversity of these bacterial communities can confound our ability to focus on potential pathogens in isolation. To develop a community-level understanding of how microorganisms colonize and move through the hospital environment, we characterized the bacterial dynamics among hospital surfaces, patients, and staff over the course of 1 year as a new hospital became operational. The bacteria in patient rooms, particularly on bedrails, consistently resembled the skin microbiota of the patient occupying the room. Bacterial communities on patients and room surfaces became increasingly similar over the course of a patient’s stay. Temporal correlations in community structure demonstrated that patients initially acquired room-associated taxa that predated their stay but that their own microbial signatures began to influence the room community structure over time. The α- and β-diversity of patient skin samples were only weakly or nonsignificantly associated with clinical factors such as chemotherapy, antibiotic usage, and surgical recovery, and no factor except for ambulatory status affected microbial similarity between the microbiotas of a patient and their room. Metagenomic analyses revealed that genes conferring antimicrobial resistance were consistently more abundant on room surfaces than on the skin of the patients inhabiting those rooms. In addition, persistent unique genotypes of Staphylococcus and Propionibacterium were identified. Dynamic Bayesian network analysis suggested that hospital staff were more likely to be a source of bacteria on the skin of patients than the reverse but that there were no universal patterns of transmission across patient rooms.

8 March 2016 in Microbiome
Verified
Journal Article
Open access
PDF file
NSNaseer Sangwan
Naseer Sangwan
FXFangfang Xia
Fangfang Xia
JGJack A. Gilbert
Jack A. Gilbert
Assembly of metagenomic sequence data into microbial genomes is of fundamental value to improving our understanding of microbial ecology and metabolism by elucidating the functional potential of hard-to-culture microorganisms. Here, we provide a synthesis of available methods to bin metagenomic contigs into species-level groups and highlight how genetic diversity, sequencing depth, and coverage influence binning success. Despite the computational cost on application to deeply sequenced complex metagenomes (e.g., soil), covarying patterns of contig coverage across multiple datasets significantly improves the binning process. We also discuss and compare current genome validation methods and reveal how these methods tackle the problem of chimeric genome bins i.e., sequences from multiple species. Finally, we explore how population genome assembly can be used to uncover biogeographic trends and to characterize the effect of in situ functional constraints on the genome-wide evolution.

26 March 2020 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
NGNilaksh Gupta
Nilaksh Gupta
JBJennifer A. Buffa
Jennifer A. Buffa
ARAdam B. Roberts
Adam B. Roberts
NSNaseer Sangwan
Naseer Sangwan
SSSarah M. Skye
Sarah M. Skye
SHStanley L. Hazen
Stanley L. Hazen
Objective: Gut microbial metabolism of dietary choline, a nutrient abundant in a Western diet, produces trimethylamine (TMA) and the atherothrombosis- and fibrosis-promoting metabolite TMA-N-oxide (TMAO). Recent clinical and animal studies reveal that elevated TMAO levels are associated with heightened risks for both cardiovascular disease and incident chronic kidney disease development. Despite this, studies focusing on therapeutically targeting gut microbiota-dependent TMAO production and its impact on preserving renal function are limited. Approach and Results: Herein we examined the impact of pharmacological inhibition of choline diet-induced gut microbiota-dependent production of TMA, and consequently TMAO, on renal tubulointerstitial fibrosis and functional impairment in a model of chronic kidney disease. Initial studies with a gut microbial choline TMA-lyase mechanism-based inhibitor, iodomethylcholine, confirmed both marked suppression of TMA generation, and consequently TMAO levels, and selective targeting of the gut microbial compartment (ie, both accumulation of the drug in intestinal microbes and limited systemic exposure in the host). Dietary supplementation of either choline or TMAO significantly augmented multiple indices of renal functional impairment and fibrosis associated with chronic subcutaneous infusion of isoproterenol. However, the presence of the gut microbiota-targeting inhibitor iodomethylcholine blocked choline diet-induced elevation in TMAO, and both significantly improved decline in renal function, and significantly attenuated multiple indices of tubulointerstitial fibrosis. Iodomethylcholine treatment also reversed many choline diet-induced changes in cecal microbial community composition associated with TMAO and renal functional impairment. Conclusions: Selective targeting of gut microbiota-dependent TMAO generation may prevent adverse renal structural and functional alterations in subjects at risk for chronic kidney disease.